Related Experiment Videos
Insulin-like growth factor-1 alters apoptotic signalling in prostate cancer
R W G Watson1, F O'Brien, R N T Coffey
1Department of Surgery, University College Dublin, Mater Misericordiae Hospital, Dublin 7, Ireland.
Prostate Cancer and Prostatic Diseases
|December 24, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Improving Medication Safety Following Neonatal Discharge: A Feasibility Study of a Parent Medication Education Intervention in Ireland.
Acta paediatrica (Oslo, Norway : 1992)·2026
Improving Medication Safety at Home: A Systematic Review of Educational Interventions for Parents of Paediatric Patients.
Acta paediatrica (Oslo, Norway : 1992)·2026
Partial nephrectomy for solid renal masses in polycystic kidneys: open surgical technique.
Annals of the Royal College of Surgeons of England·2025
Central Blood Pressure and Augmentation Index in Older Adults With Intellectual Disabilities.
Journal of intellectual disability research : JIDR·2025
An evaluation of selected (Q)SARs/expert systems for predicting skin sensitisation potential.
SAR and QSAR in environmental research·2018
Application of IATA - A case study in evaluating the global and local performance of a Bayesian network model for skin sensitization.
SAR and QSAR in environmental research·2017
Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.
Prostate cancer and prostatic diseases·2026
Oncological and functional outcomes of focal irreversible electroporation for localised prostate cancer: a single institution series of 171 cases.
Prostate cancer and prostatic diseases·2026
Correlation of intraprostatic lesional SUVmax during PSMA PET/CT and adverse pathology at radical prostatectomy.
Prostate cancer and prostatic diseases·2026
Prostate size and its effect on sexual function following convective water vapor thermal therapy.
Prostate cancer and prostatic diseases·2026
Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report.
Prostate cancer and prostatic diseases·2026
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.
Prostate cancer and prostatic diseases·2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.
The Journal of experimental medicine·2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.
Molecular cancer therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.
Molecular pharmaceutics·2026